AM Markets Need to Know: Pharma tariffs soon, Gulf states look to bypass Hormuz, and moreApril 2, 2026
Share Facebook Twitter LinkedIn Pinterest Email Dynavax projects HEPLISAV-B revenue of $305M-$325M for 2025 amid expanding hepatitis B market
AM Markets Need to Know: Pharma tariffs soon, Gulf states look to bypass Hormuz, and moreApril 2, 2026